Q2 2025 Holdings
Filed 2025-08-14 | 54 holdings | $311.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $22.2M | 2,372,634 | 7.1% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $20.8M | 1,300,860 | 6.7% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $18.7M | 528,115 | 6.0% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $16.6M | 1,265,672 | 5.3% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $15.9M | 52,694 | 5.1% |
| Merus N V | COM | N5749R100 | $14.0M | 266,094 | 4.5% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $13.3M | 201,452 | 4.3% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $13.0M | 266,774 | 4.2% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $11.2M | 176,752 | 3.6% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $10.0M | 351,124 | 3.2% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $9.9M | 707,915 | 3.2% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $9.6M | 270,144 | 3.1% |
| Geron Corp(GERN) | COM | 374163103 | $9.4M | 6,649,244 | 3.0% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $8.8M | 250,438 | 2.8% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $8.6M | 631,586 | 2.7% |
| Uniqure NV(QURE) | SHS | N90064101 | $8.0M | 572,615 | 2.6% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $6.8M | 601,781 | 2.2% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $6.2M | 116,779 | 2.0% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $6.2M | 61,578 | 2.0% |
| Surrozen Inc(SRZN) | COM NEW | 86889P208 | $6.1M | 686,539 | 2.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $5.9M | 900,338 | 1.9% |
| Lenz Therapeutics Inc(LENZ) | COM | 52635N103 | $5.4M | 183,912 | 1.7% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $4.6M | 59,828 | 1.5% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $4.4M | 386,790 | 1.4% |
| Vistagen Therapeutics Inc(VTGN) | COM | 92840H400 | $4.1M | 2,413,254 | 1.3% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $3.7M | 84,466 | 1.2% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $3.5M | 165,885 | 1.1% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $3.5M | 1,143,677 | 1.1% |
| Helix Acquisition Corp II | CL A ORD SHS | G4444H101 | $3.3M | 315,812 | 1.1% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $3.1M | 329,254 | 1.0% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $2.9M | 205,672 | 0.9% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $2.9M | 644,654 | 0.9% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $2.8M | 1,203,941 | 0.9% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $2.8M | 152,652 | 0.9% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $2.5M | 174,754 | 0.8% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $2.5M | 4,672 | 0.8% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $2.4M | 54,630 | 0.8% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $2.1M | 89,933 | 0.7% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $2.0M | 200,785 | 0.7% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $1.6M | 141,021 | 0.5% |
| Perceptive Cap Solutions COR | CL A ORD SHS | G70077105 | $1.6M | 150,000 | 0.5% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $1.4M | 32,255 | 0.4% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $1.2M | 100,826 | 0.4% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $1.1M | 208,800 | 0.3% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $926.8K | 16,770 | 0.3% |
| Tectonic Therapeutic Inc(TECX) | COM | 878972108 | $794.8K | 40,000 | 0.3% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $759.2K | 283,286 | 0.2% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $700.6K | 7,407 | 0.2% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $671.3K | 87,748 | 0.2% |
| Roivant Sciences LTD(ROIV)Call | SHS | G76279101 | $617.6K | 915,000 | 0.2% |